GlassScriptPhysician profile
Umran Senyer
NPI 1477937688
$581.25
in general payments reported to CMS, 2019-2025
10 companies · $28.29 in 2025
The $28.29 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.43 · 2022: $33.45 · 2023: $248 · 2024: $175 · 2025: $28.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mirum Pharmaceuticals, INC. | $174.60 | 2024 | Livmarli |
| Ironwood Pharmaceuticals, INC | $88.39 | 2023 | Linzess |
| Regeneron Healthcare Solutions, INC. | $82.53 | 2023 | Dupixent |
| Qol Medical, LLC | $53.91 | 2023 | Sucraid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.73 | 2021-2022 | |
| Abbvie INC. | $45.64 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $28.29 | 2025 | Iqirvo |
| Vertex Pharmaceuticals Incorporated | $23.65 | 2023 | Trikafta |
| Nestle Healthcare Nutrition INC. | $18.45 | 2021 | |
| Braintree Laboratories, INC. | $15.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umran Senyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.